Pfizer secures exclusive option to acquire gene therapy company vivet therapeutics

by Ysios Capital

​Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfize...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Josep Tabernero: 'The covid-19 has been ...

by GENESIS Biomed

Dr. Josep Tabernero is one of the most recognized and prestigious figu...

Photos Stream